… InterGroup Corporation (NASDAQ: INTG) (the “Company”) today announced that it has … received a letter from The Nasdaq Stock Market, LLC (“Nasdaq … ”) confirming that it has regained compliance with Nasdaq …

… (GLOBE NEWSWIRE) -- Fitell Corporation (Nasdaq: FTEL) (the “Company”), an online … , today announced that it will effect a share consolidation of its ordinary shares … FleetX, in over 2,000 stock-keeping units (SKUs). For additional …

… stockholder rights law firm, announces that a class action … (“Cytokinetics” or the “Company”) (NASDAQ:CYTK) in the United States … or otherwise acquired Cytokinetics shares and suffered a loss, … any questions concerning this announcement or your rights or …

… . II (the “Company”) announced today the pricing of its … of $11.50 per share, subject to certain adjustments. … shares and warrants are expected to be listed on Nasdaq … merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or …

… . (Nasdaq: FTHM), a national, technology-driven real estate services platform, today announced … additional 15% of the shares of common stock offered in the underwritten … statement relating to the shares of common stock proposed to be issued …

… -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage … heart disease, today announced that it granted stock options to purchase … stock options have an exercise price of $1.20 per share … original number of shares subject to the stock option shall …

… (Nasdaq: CYTK) today announced that on September 15, 2025 it granted stock … price of $49.44 per share, which is equal to … grant date and the remaining shares thereafter vesting in monthly … ;48th of the shares underlying such stock options over the subsequent …

… NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage … inducible urticaria (CIndU) and asthma, announced today that it intends to … expenses. All of the shares of common stock, pre-funded warrants and …

… Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq … clinical-stage biopharmaceutical company, today announced the resignation of Daniel Soland … , NJ. The Company’s ordinary shares are traded on segment B …

… steatohepatitis (MASH), today announced that it granted equity … 2,015 shares of Madrigal’s common stock, and in … stock units. Options have an exercise price of $425.60 per share … Pharmaceuticals Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a …